Lipid nanoparticles (LNPs) transport small molecules into the body. The most well-known LNP cargo is mRNA, the key constituent of some of the early vaccines against COVID-19. But that is just one ...

Among the new vaccine technologies, nanoparticle-based vaccines have unique properties that are highly designable and programable. I will discuss our efforts on the development of next-generation ...

Novavax shares fell 11.2% during Wednesday's session. Vaccine stocks are volatile after the first US bird flu death and a CDC report on rising respiratory illnesses.

"Developing effective influenza vaccines or vaccination strategies that can confer cross-protection against variant influenza viruses is a high priority to mitigate the public health consequences ...

In response, DXVX has adopted a nanoparticle-based universal coronavirus vaccine developed at Stanford University. Through the dedication and persuasive efforts of Chong-Yoon Lim, Chairman of the ...

Despite the success of mRNA vaccines, the unmet needs include limited effectiveness against viral mutations, insufficient long-term immunity, high royalty costs, and the need for highly cold chain ...

By packaging the nucleic acid polymer in well-defined nanoparticles, LNPs protect the nucleic acid payload in vivo and facilitate intracellular delivery following uptake into target cells by ...

The vaccine developed by DX&VX utilizes nanoparticles to form Virus-Like Particle (VLP) structures as antigens. Unlike traditional vaccines that rely solely on specific spike proteins, this approach ...

By packaging the nucleic acid polymer in well-defined nanoparticles, LNPs protect the nucleic acid payload in vivo and facilitate intracellular delivery following uptake into target cells by ...

The vaccine developed by DX&VX utilizes nanoparticles to form Virus-Like Particle (VLP) structures as antigens. Unlike traditional vaccines that rely solely on specific spike proteins, this ...